Diseases | Regulators | Effects | Mechanism | Species and cells | Ref. |
---|---|---|---|---|---|
Osteoporosis | METTL3↑、IGF2BP1 | inhibition | Runx2↑ | Human BMSCs | |
YTHDF1↑ | inhibition | ZNF839↑/ Runx2↑ | Human BMSCs | [177] | |
FTO↑ | inhibition | RBM4↑/ Runx2↑ | Human DPSCs | [178] | |
METTL3↑、IGF2BP2/3 | inhibition | ACLY↑、SLC25A1↑ | Human DPSCs | [179] | |
METTL3↑ | promotion | ASK1-p38↑、SLC7A11 ↑、GPX4↑ | Mouse MC3T3-E1 cells | [180] | |
FTO↑、YTHDF1 | inhibition | PPARG↓ | Human MSCs | [181] | |
FTO↑ | inhibition | Hsp70↑/NF-κB↓ | Mouse Osteoblasts | [182] | |
METTL3↑ | promotion | FSH↑/ CREB phosphorylation↑/ METTL3↑/CTSK↑ | Mouse Osteoblasts | [183] | |
METTL14↑、YTHDF2 | inhibition | zoledronic acid↑/ METTL14↑/ NFATc1↓ | Mouse RAW264.7 monocytic cells | [184] | |
METTL14↑ | inhibition | TCF1↓、SIRT1↓/ Wnt/β-catenin↑ | Mouse BMSCs and BMM s | ||
FTO↑ | inhibition | TLR4↓ | Mouse RAW264.7 monocytic cells | [187] | |
IVDD | METTL3↑ | promotion | SIAH1↑/ XIAP↓ | Human NPCs | [192] |
METTL14↑、IGF2BP2 | promotion | NLRP3↑/ IL-1β↑、IL-18↑ | Human NPCs | [193] | |
METTL14↑、IGF2BP1 | promotion | DIXDC1↑/ Wnt/β-catenin↑ | Human NPCs | [194] | |
METTL16↑ | promotion | oxidative stress↑/ METTL16↑/MAT2A↓ | Human NPCs | [195] | |
ALKBH5↑、YTHDF2 | inhibition | FIP200↑/ autophagic flux↑ | Human NPCs | [196] | |
ALKBH5↑、YTHDF2 | Promotion | DNMT3B↑/E4F1↓ | Human NPCs | [197] | |
METTL3↑ | Promotion | TNF-α↑/ METTL3↑/ miR-143-3p↑/ SOX5↓ | Human NPCs | [198] | |
METTL14↑ | Promotion | miR-34a-5p↑/ SIRT1↓ | Human NPCs | [199] | |
WTAP↑、YTHDF2 | Promotion | lncRNA NORAD↓/PUMILIO sequestraion↓/ PUM1/2 activity↑/ E2F3↓ | Human NPCs | [200] | |
YTHDF2↑ | inhibition | CirGPATCH2L↓/ phosphorylation of TRIM28↑/ p53↑ | Human NPCs | [201] | |
METTL3↑ | Promotion | SOX9↓/ COL2A1↓ | Human endplate chondrocytes | [202] | |
METTL3↑ | Promotion | miR-126-5p↑/PIK3R2↓/PI3K/AKT↓ | Human endplate chondrocytes | [154] |